Cross trial esophagus updated result | PPT
Frontiers | Response Prediction to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma Using Delta-Radiomics Based on Sequential Whole-Tumor ADC Map
Cross trial esophagus updated result | PPT
integration NEOPEC-trial within CROSS-trial. CRT chemoradiotherapy, PET... | Download Scientific Diagram
Surgery or Surveillance for Esophageal Squamous Cell Carcinoma With Clinical Complete Response After Neoadjuvant Chemoradiotherapy - ScienceDirect
Survival Between Neoadjuvant and Definitive Chemoradiotherapy In Locally Advanced Esophageal Cancer | Chaochankit | Journal of Gastroenterology and Hepatology Research
Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study | BMC Cancer | Full Text
Cross trial esophagus updated result | PPT
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in ...
CROSS Trial - Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
Flow chart depicting the enrollment process. Modified CROSS neoadjuvant... | Download Scientific Diagram
CROSS Trial - Neoadjuvant ChemoRT for Esophageal Cancer
Preoperative pembrolizumab combined with chemoradiotherapy for esophageal squamous cell carcinoma: Trial design - ScienceDirect
Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity | Strahlentherapie und Onkologie
Frontiers | Long-Term Efficacy of Neoadjuvant Concurrent Chemoradiotherapy for Potentially Resectable Advanced Siewert Type II and III Adenocarcinomas of the Esophagogastric Junction
Biomedicines | Free Full-Text | Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era
Yüksel Ürün: KEYNOTE-412 trial shows pembrolizumab + chemoradiotherapy doesn't significantly improve event-free survival in unselected advanced head and neck squamous cell carcinoma vs placebo - OncoDaily
Patient selection process. nCRT neoadjuvant chemoradiotherapy, dCRT... | Download Scientific Diagram
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial - ScienceDirect
Cihan Gani on X: "🚨Ten-year data from CROSS the cross trial 👉Rand. trial of surgery alone vs. pre-OP ChemoRad in esophageal cancer. 👉OS benefit persists during long-term follow-up. #esocsm #radonc https://t.co/zCQhg8ZEoW https://t.co/5WtvbRePz1" /
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial - ScienceDirect
A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of Surgery As Needed for Oesophageal cancer-2. - Abstract - Europe PMC
Promising Efficacy with FLOT-CROSS in Patients with Oligometastatic Esophageal Adenocarcinoma
